Efficacy and tolerability of intralesional bleomycin in dermatology – a systematic review

Bleomycin is widely used as off-label treatment for various dermatological indications. However, a much-needed critical appraisal of the currently available evidence is lacking. We, therefore, evaluated the quality of clinical evidence for the efficacy and safety of intralesional bleomycin treatment for dermatological indications with the aim to provide evidence-based recommendations for clinical practice. A systematical database search in Pubmed, Embase, Medline Ovid, Web of Science, Cochrane central and Google Scholar was conducted.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Source Type: research